H pylori May Undermine Immunotherapy Response in Gastric Cancer H pylori May Undermine Immunotherapy Response in Gastric Cancer
H pylori infection was associated with shorter progression-free and overall survival. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Helicobacter Pylori | Immunotherapy | Study